ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,277.51
0.80%
Dow Jones
38,686.32
1.51%
US Dollar vs MXN
16.99024
-0.30%
Brent Oil
81.295
0.00%
Bitcoin
67,621.70
0.21%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. GoodRx Holdings Inc (GDRX)

  7. GoodRx Holdings Inc (GDRX) Noticias

GDRX

GoodRx (GDRX)

GoodRx Holdings Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:GDRX
FechaHoraFuenteTítuloSímboloCompañía
30/05/202415:29Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:GDRXGoodRx Holdings Inc
30/05/202415:25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GDRXGoodRx Holdings Inc
30/05/202415:05Business WireSimon Patterson Joins GoodRx Board of DirectorsNASDAQ:GDRXGoodRx Holdings Inc
30/05/202407:35Business WireGoodRx Named One of the 2024 TIME100 Most Influential CompaniesNASDAQ:GDRXGoodRx Holdings Inc
29/05/202404:45PR Newswire (US)Shareholders that lost money on GoodRx Holdings, Inc.(GDRX) should contact The Gross Law Firm about pending Class Action - GDRXNASDAQ:GDRXGoodRx Holdings Inc
22/05/202408:00Business WireGoodRx Offers Discounts of Up to 43% On Fertility TreatmentsNASDAQ:GDRXGoodRx Holdings Inc
15/05/202405:00Business WireGoodRx and Kroger Sign Direct Contracting AgreementNASDAQ:GDRXGoodRx Holdings Inc
14/05/202404:45PR Newswire (US)The Gross Law Firm Notifies Shareholders of GoodRx Holdings, Inc.(GDRX) of a Class Action Lawsuit and an Upcoming DeadlineNASDAQ:GDRXGoodRx Holdings Inc
10/05/202404:45PR Newswire (US)GoodRx Holdings, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before June 21, 2024 to Discuss Your Rights - GDRXNASDAQ:GDRXGoodRx Holdings Inc
09/05/202414:52Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GDRXGoodRx Holdings Inc
09/05/202405:05Business WireGoodRx Reports First Quarter 2024 ResultsNASDAQ:GDRXGoodRx Holdings Inc
08/05/202416:48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GDRXGoodRx Holdings Inc
07/05/202405:20PR Newswire (US)Shareholders that lost money on GoodRx Holdings, Inc.(GDRX) Urged to Join Class Action - Contact The Gross Law Firm to Learn MoreNASDAQ:GDRXGoodRx Holdings Inc
03/05/202404:45PR Newswire (US)Class Action Filed Against GoodRx Holdings, Inc. (GDRX) Seeking Recovery for Investors - Contact The Gross Law FirmNASDAQ:GDRXGoodRx Holdings Inc
24/04/202407:00Business WireGoodRx Announces Date for 2024 Investor DayNASDAQ:GDRXGoodRx Holdings Inc
11/04/202415:09Business WireGoodRx Announces Date for First Quarter 2024 Earnings Release and Conference CallNASDAQ:GDRXGoodRx Holdings Inc
14/03/202407:00Business WireGoodRx Interim CEO Extends Commitment to CompanyNASDAQ:GDRXGoodRx Holdings Inc
29/02/202413:37Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:GDRXGoodRx Holdings Inc
29/02/202413:04Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:GDRXGoodRx Holdings Inc
29/02/202405:02Business WireGoodRx Reports Fourth Quarter and Full Year 2023 ResultsNASDAQ:GDRXGoodRx Holdings Inc
20/02/202415:05Business WireGoodRx to Participate in Upcoming Investor ConferencesNASDAQ:GDRXGoodRx Holdings Inc
01/02/202415:05Business WireGoodRx Announces Date for Fourth Quarter and Full Year 2023 Earnings Release and Conference CallNASDAQ:GDRXGoodRx Holdings Inc
22/01/202413:15Business WireGoodRx Announces Proposed Refinancing of First Lien Credit FacilitiesNASDAQ:GDRXGoodRx Holdings Inc
11/01/202408:00Business WireThe GoodRx Effect: Delivering a Transformative Impact on the U.S. Healthcare System through Prescription SavingsNASDAQ:GDRXGoodRx Holdings Inc
10/01/202408:01Business WireGoodRx Announces Preliminary Fourth Quarter and Full Year 2023 Results and Early Expectations for First Quarter and Full Year 2024NASDAQ:GDRXGoodRx Holdings Inc
22/12/202308:00Business WireGoodRx Appoints Kelly J. Kennedy to Board of DirectorsNASDAQ:GDRXGoodRx Holdings Inc
13/12/202315:05Business WireGoodRx to Participate in the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:GDRXGoodRx Holdings Inc
16/11/202315:05Business WireGoodRx to Participate in the Evercore ISI HealthCONx ConferenceNASDAQ:GDRXGoodRx Holdings Inc
09/11/202305:02Business WireGoodRx Reports Third Quarter 2023 ResultsNASDAQ:GDRXGoodRx Holdings Inc
19/10/202308:00Business WireGoodRx Announces New Way for Consumers to Access Sanofi’s Lantus for $35 at Over 70,000 Pharmacies NationwideNASDAQ:GDRXGoodRx Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:GDRX

Su Consulta Reciente

NASDAQ
NVDA
NVIDIA
NYSE
MCD
McDonalds
NASDAQ
AAPL
Apple
CCOM
OILBRENT
Brent Oil
NYSE
KO
Coca Cola
USOTC
BNPQY
BNP Paribas (QX)
COIN
SOLUSD
Solana
CCOM
US30
US 30
FX
EURMXN
Euro vs MXN
NASDAQ
MSFT
Microsoft
USOTC
BASFY
BASF (QX)
FX
USDMXN
US Dollar vs MXN
NYSE
DIS
Walt Disney
COIN
ETHUSD
Ethereum
NYSE
BAC
Bank of America
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados